Add BrightSurf on Google Email

Oncotarget | Novel prognostic index to predict survival outcomes in gastric cancer patients

Researchers have developed a novel prognostic index to predict survival outcomes in gastric cancer patients. The inflammation-combined prognostic index (ICPI) combines three biomarkers - lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio - to provide a personalized prognosis for each patient.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateFeb 14, 2023

NUS researchers find differential impacts of Blastocystis strains on gut health

Researchers identified two Blastocystis strains, ST4 and ST7, with contrasting effects on the gut microbiome, promoting or disrupting a healthy balance. The study's findings suggest that geographical prevalence may influence the strain's impact on intestinal disease.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalTheranostics·TypeRandomized controlled/clinical trial·DateFeb 12, 2023

E-cigarettes potentially harmful: PET imaging shows greater lung inflammation in e-cigarette users than cigarette smokers

A new study published in The Journal of Nuclear Medicine found that e-cigarette users have greater lung inflammation than cigarette smokers and non-smokers. The study used PET imaging to compare lung inflammation between e-cigarette users and cigarette smokers, revealing a unique inflammatory response in the lungs.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJan 26, 2023

Study explores effects of resistance training in older adults at the cellular level

A new study by researchers at Florida Atlantic University explored the effects of resistance training on older adults' cellular level. The study found that resistance training did not significantly affect inflammatory proteins or redox balance markers, but showed a significant reduction in a specific protein ratio. This may support the...

SourceFlorida Atlantic University·JournalAntioxidants·TypeExperimental study·DateJan 17, 2023

A blood vessel protein reduces mortality in infectious disease

A new study by Osaka University researchers demonstrates that the endothelial cell-specific protein Robo4 plays a crucial role in reducing mortality in severe infection. By upregulating Robo4 expression, a drug treatment can decrease vascular permeability and increase survival rates.

SourceOsaka University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 17, 2023

How gut bacteria evade the immune system

Researchers identified a new type of flagellin in the human gut that binds to Toll-like receptor 5 without inducing an inflammatory response. This discovery provides a mechanism for the immune system to tolerate beneficial microbes while remaining responsive to pathogens.

SourceMax-Planck-Gesellschaft·JournalScience Immunology·TypeMeta-analysis·DateJan 16, 2023

Mouse study suggests new therapeutic strategy to reduce cardiovascular disease in cancer survivors

Researchers at Memorial Sloan Kettering Cancer Center discovered that common cancer treatments cause long-term damage to heart tissue by activating a key inflammatory signaling pathway. Inhibiting this pathway may reduce the risk of cancer survivors developing heart disease later in life.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·TypeExperimental study·DateDec 19, 2022

Racism takes its toll on brain and body

A new study finds that discrimination influences the central and enteric nervous systems, altering the bidirectional signaling between the brain and gut microbiome. This leads to changes in systemic inflammation, emotional arousal, and psychological symptoms across different racial and ethnic groups.

SourceElsevier·JournalBiological Psychiatry·TypeData/statistical analysis·DateDec 13, 2022

Combined effect of bacteria and iron levels on the progression of colorectal cancer

Researchers found that excessive iron accumulation accelerates tumor growth in F. nucleatum-positive colorectal cancer by enhancing inflammatory responses in immune cells, promoting interpatient prognostic variability. Iron levels also modulate macrophage expression profiles, transforming them into pro-tumor cells expressing CCL8.

SourceKumamoto University·JournalJCI Insight·TypeExperimental study·DateNov 9, 2022

A new nanoparticle to act at the heart of cells

Researchers have developed a transport nanoparticle to deliver an anti-inflammatory drug, Necrosulfonamide (NSA), directly into macrophages to combat inflammatory overactivation. The mesoporous silica nanoparticle is fully biodegradable and non-toxic, showing remarkable efficacy in reducing inflammation.

SourceUniversité de Genève·JournalJournal of Controlled Release·TypeNews article·DateNov 8, 2022

Portland State study finds diet high in saturated fat can reprogram immune cells in mice

Researchers discovered that a ketogenic diet high in saturated fats can reprogram the mouse immune system, making it better at fighting off infections but more susceptible to systemic inflammatory conditions. The study also found that another type of fat, oleic acid, may be able to counteract the harmful effects of palmitic acid.

SourcePortland State University·JournaleLife·TypeExperimental study·DateNov 7, 2022

New cancer drug candidate targets immune system “brakes”

Researchers have designed a potential therapeutic that dampens the activity of regulatory T cells, which can prevent the immune system from unleashing its full potential against tumor cells. The molecule, known as FOX3P, acts as a transcription factor for many Treg genes but isn't vital for other types of T cells.

SourceUniversity of Chicago·JournalProceedings of the National Academy of Sciences·DateOct 18, 2022

Powerful enzyme that tamps down inflammation holds promise for protecting the eyes in diabetes, premature birth

Researchers found that increasing arginase 1 availability helps alleviate unhealthy responses and interrupt destructive inflammation in diabetic retinopathy and retinopathy of prematurity. This is achieved by reducing L-arginine levels, which in turn reduces inducible nitric oxide synthase activity.

SourceMedical College of Georgia at Augusta University·JournalCell Death and Disease·DateOct 12, 2022

Lifestyle factors may act as preventative measures against severe COVID-19

A new study suggests that lifestyle choices can help prevent severe COVID-19 by reducing chronic inflammation and regulating the immune system. By adopting healthy habits such as regular exercise, balanced diet, and stress management, individuals can lower their risk of developing severe disease and mitigate post-infection symptoms.

SourceUniversity of Colorado at Boulder·JournalAmerican Journal of Lifestyle Medicine·DateOct 12, 2022

Study uncovers mechanism behind virus-induced heart inflammation, suggests potential therapeutic target

Researchers have identified two NLRP sensors, NLRP1 and CARD8, as key players in Coxsackievirus B3-induced heart inflammation. Targeting CARD8 may prevent CVB3 infections from progressing to heart failure. The study provides new insights into the inflammatory response triggered by this common viral cause of viral myocarditis.

SourceDuke-NUS Medical School·JournalJournal of Experimental Medicine·TypeExperimental study·DateSep 21, 2022

When recovery goes awry

A new study from Harvard Medical School reveals that patients who recover well after cardiovascular surgery exhibit precise paths for white blood cell and platelet counts. These trajectories can be used to monitor recovery in a personalized way, enabling clinicians to intervene earlier when necessary.

SourceHarvard Medical School·JournalNature Communications·DateAug 22, 2022

Mechanistic insights into contact hypersensitivity could pave the way for drug discovery

A study by Japanese researchers from Fujita Health University sheds light on the molecular mechanisms of contact dermatitis, revealing that neutrophil extracellular traps play a key role in the condition. The team's findings suggest that inhibiting NET formation could be a new therapeutic strategy for treating contact dermatitis.

SourceFujita Health University·JournalScientific Reports·TypeExperimental study·DateAug 17, 2022

The "electric pill"

Researchers at Vienna University of Technology have successfully stimulated the auricular vagus nerve to reduce inflammation in severe COVID-19 cases, using a novel closed-loop control system. The therapy, dubbed an 'electric pill', has shown promising results in reducing inflammation and promoting healing.

SourceVienna University of Technology·JournalFrontiers in Physiology·TypeExperimental study·DateAug 3, 2022

Anti-inflammatory compound shows potential in treating patients with severe COVID-19

A multi-site trial found OP-101 to be effective in reducing inflammatory markers and markers of neurological injury, with improved outcomes for patients. The study showed a significant reduction in the composite outcome of mechanical ventilation or death at 30 and 60 days after treatment.

SourceUniversity of Texas Health Science Center at Houston·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateJul 20, 2022

Safety first: How stigma may impact health

A new theory suggests that lack of perceived safety in marginalized communities can have a direct impact on physical and mental health. This concept challenges decades-old thinking that minority stress is the primary cause of health disparities in the LGBTQ community.

SourceUniversity of Utah·JournalNeuroscience & Biobehavioral Reviews·TypeLiterature review·DateJul 6, 2022

COVID-19 on the brain: Neurological symptoms persist in majority of long-haulers

A UC San Diego longitudinal study found that most COVID-19 long-haulers continue to suffer from neurological symptoms six months after infection, with memory impairment and decreased concentration being the most prevalent. Researchers identified a new subgroup with advanced symptoms, including tremor and difficulty balancing.

SourceUniversity of California - San Diego·JournalAnnals of Clinical and Translational Neurology·DateJun 15, 2022

Ultra-thin, flexible probe provides neural interface that’s minimally invasive and long-lasting

Researchers at the University of California San Diego have developed a tiny, flexible neural probe that can record and stimulate neural activity while minimizing injury to surrounding tissue. The probe is ideal for studying peripheral nerves or the spinal cord, where traditional probes may not fit due to its small size and flexibility.

SourceUniversity of California - San Diego·JournalNature Communications·TypeExperimental study·DateJun 9, 2022

LSU Health study shows promise of NB-UVB phototherapy in hospitalized COVID-19 patients

A randomized, placebo-controlled pilot study found that NB-UVB phototherapy decreased mortality in hospitalized COVID-19 patients with no adverse events reported. The treatment was effective in both vaccinated and unvaccinated patients, with reduced pathologic inflammation and improved intracellular killing of pathogens.

SourceLouisiana State University Health Sciences Center·JournalExperimental Dermatology·TypeRandomized controlled/clinical trial·DateJun 3, 2022